Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1664-1671

  Lysenko, Elena S ^a   Gould, Jane ^a   Bals, Robert ^a   Wilson, James M ^a   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLINE; MEMBRANE LIPID; PEPTIDE; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE; SODIUM CHLORIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC TRANSCRIPTION; HAEMOPHILUS INFLUENZAE; HOST; HUMAN; NASOPHARYNX; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CARRIER PROTEINS; HAEMOPHILUS INFLUENZAE; HUMANS; NASOPHARYNX; PHOSPHORYLCHOLINE;

EID: 0033976515     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1664-1671.2000     Document Type: Article

References (39)

1. Agerberth, B., H. Gunne, J. Odeberg, P. Kogner, H. Bowman, and G. Gudmundsson. 1995. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 92:195-199.
2. Ausubel, F. M., et al. (ed.). 1999. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
3. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Bafna, M. Zasloff, and J. M. Wilson. 1998. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
4. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541-9546.
5. Boman, H. 1991. Antibacterial peptides: key components needed in immunity. Cell 65:205-207.
6. Briles, D. E., G. Scott, B. Gray, M. J. Crain, M. Blaese, M. Nahm, V. Scott, and P. Haber. 1987. Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J. Infect. Dis. 155:1307-1314.
7. Cole, A., P. Dewan, and T. Ganz. 1999. Innate antimicrobial activity of nasal secretions. Infect. Immun. 67:3267-3275.
8. Deutsch, J., M. Salman, and S. Rottem. 1995. An unusual polar lipid from the cell membrane of Mycoplasma fermentans. Eur. J. Biochem. 227:897-902.
9. Diamond, G., M. Zasloff, H. Eck, M. Brasseur, W. L. Maloy, and C. L. Bevins. 1991. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc. Natl. Acad. Sci. USA 88:3952-3956.
10. Frohm, M., B. Agerberth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and G. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258-15263.
11. Gazit, E., A. Boman, H. Boman, and Y. Shai. 1995. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry 34:11479-11488.
12. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
13. Guo, L., K. Lim, J. S. Gunn, B. Bainbridge, R. Darveau, M. Hackett, and S. I. Miller. 1996. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253.
14. Guo, L., K. Lim, C. Poduje, M. Daniel, J. Gunn, M. Hackett, and S. Miller. 1998. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198.
15. High, N. J., M. E. Deadman, and E. R. Moxon. 1993. The role of a repetitive DNA motif (5′-CAAT-3′) in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope αGal(1-4)βGal. Mol. Microbiol. 9:1275-1282.
16. Johansson, J., G. H. Gudmundsson, M. E, Rottenberg, K. D. Berndt, and B. Agerberth. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273:3718-3724.
17. Joris, L., I., Dab, and P. Quinton. 1993. Elemental composition of human airway surface fluid in healthy and diseased airways. Am. Rev. Respir. Dis. 148:1633-1637.
18. Kim, J., and J. Weiser. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177:368-377.
19. Kolberg, J., E. A. Holby, and E. Jantzen. 1997. Detection of the phosphorylcholine epitope in streptococci, Haemophilus and pathogenic neisseriae by immunoblotting. Microb. Pathog. 22:321-329.
20. Lysenko, E., J. Richards, A. Cox, M. Kapoor, and J. Weiser. The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein mediated killing. Mol. Microbiol., in press.
21. Michalka, J., and S. Goodgal. 1969. Genetic and physical map of the chromosome of Hemophilus influenzae. J. Mol. Biol. 45:407-421.
22. Mosser, J. L., and A. Tomasz. 1970. Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an enzyme. J. Biol. Chem. 245:287-298.
23. Nilsson, M., B. Sandstedt, O. Sorensen, G. Weber, N. Borregaard, and M. Stahle-Backdahl. 1999. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in the human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67:2561-2566.
24. Nordenstam, G., B. Andersson, D. Briles, J. W. J. Brooks, A. Oden, A. Svanborg, and C. S. Eden. 1990. High anti-phosphorylcholine antibody levels and mortality associated with pneumonia. Scand. J. Infect. Dis. 22:187-195.
25. Risberg, A., H. Masoud, A. Martin, J. Richards, E. Moxon, and E. Schweda. 1999. Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by a capsule-deficient strain of Haemophilus influenzae Rd. Eur. J. Biochem. 261:171-180.
26. Risberg, A., E. K. H. Schweda, and P.-E. Jansson. 1997. Structural studies of the cell-envelope oligosaccharide from lipopolysaccharide of Haemophilus influenzae strain RM 118-28. Eur. J. Biochem. 243:701-707.
27. Schenkein, H., J. Gunsolley, A. Best, M. Harrison, C. Hahn, J. Wu, and J. Tew. 1999. Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. Infect. Immun. 67:4814-4818.
28. Silvestro, L., K. Gupta, J. N. Weiser, and P. H. Axelson. 1997. The concentration-dependent membrane activity of cecropin A. Biochemistry 36:11452-11460.
29. Singh, P., H. Jia, K. Wiles, J. Hesselberth, L. Liu, B. Conway, E. Greenberg, E. Valore, M. Welsh, T. Ganz, B. Tack, and P. McCray, Jr. 1998. Production of beta-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95:14961-14966.
30. Sitaram, N., and R. Nagaraj. 1993. Interaction of the 47-residue antibacterial peptide seminalplasmin and its 13-residue fragment which has antibacterial and hemolytic activities with model membranes. Biochemistry 32: 3124-3130.
31. Sorensen, O., K. Arnljots, J. Cowland, D. Bainton, and N. Borregaard. 1997. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90:2796-2803.
32. Turner, J., Y. Cho, N. Dinh, A. Waring, and R. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42:2206-2214.
33. Weiser, J. N. 1993. The oligosaccharide of Haemophilus influenzae. Microb. Pathog. 13:335-342.
34. Weiser, J. N. 1999. Phase variation of Streptococcus pneumoniae, p. 225-231. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. ASM Press, Washington, D.C.
35. Weiser, J. N., R. Austrian, P. K. Sreenivasan, and H. R. Masure. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:2582-2589.
36. Weiser, J. N., J. M. Love, and E. R. Moxon. 1989. The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 59:657-665.
37. Weiser, J. N., and N. Pan. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775.
38. Weiser, J. N., N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. C. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631-640
39. Weiser, J. N., M. Shchepetov, and S. T. H. Chong. 1997. Decoration of lipopolysaccaride with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 65:943-950.